We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Researchers Pinpoint Genetic Basis for Lactation

By Biotechdaily staff writers
Posted on 08 Jan 2003
Researchers have found that the gene that codes for the purine catabolic enzyme xanthine oxidoreducase (XOR) is necessary for maintaining lactation in mice and may play a similar role in humans. More...
Their finding was published in the December 15, 2002, issue of Genes & Development.

Knowing that the XOR gene is highly expressed in lactating epithelial tissue, researchers from the University of Utah (Salt Lake City, USA) created two strains of XOR deficient mice. One strain lacked both working copies of the gene, while the other (heterozygotes) contained one copy.

Mice with no XOR died by six weeks of age, showing that XOR has more than one metabolic role to play. The mice with one copy of XOR appeared normal, healthy and fertile, but their pups all died about 12 days after birth. Further study showed that XOR is required for the envelopment of milk fat droplets with a phospholipid bilayer that is necessary for their secretion from the mammary epithelium. The inability of heterozygous XOR-mutant females to secrete milk fat droplets caused severe tissue damage, resulting in the collapse of the mammary epithelium and the subsequent premature involution of the mammary gland. Unable to receive milk from their mothers, the pups starved to death.

The finding that two functional copies of the XOR gene are necessary for females to secrete fat into milk not only broadens the known functional range of XOR, it lends important molecular insight into the process of lactation, and suggests that human females with mutations in the XOR gene may be potential candidates for lactation insufficiencies. Approximately 5% of new mothers have lactation difficulties.



Related Links:
University of Utah

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.